Lunit

Lunit

Medical Imaging & Radiology

About Lunit

Lunit is a global medical AI company transforming cancer detection and treatment through cutting-edge artificial intelligence. The company develops AI software that converts complex clinical data into actionable insights across the entire cancer care pathway, from early screening to precision oncology. Lunit's cancer screening portfolio includes INSIGHT MMG for 2D mammography, INSIGHT DBT for 3D breast imaging, and INSIGHT CXR for chest X-ray analysis, alongside the Volpara suite (Scorecard, Analytics, Live, Risk Pathways) for comprehensive breast imaging workflow management. In precision oncology, Lunit offers the SCOPE platform, including SCOPE IO for tumor microenvironment analysis, SCOPE IHC Suite for immunohistochemistry quantification (including uIHC, HER2, and PD-L1 biomarkers), and SCOPE GP for genotype prediction. The company's AI models are trained on diverse global datasets and designed for seamless integration into real-world clinical workflows. Lunit serves over 10,000 customer sites across 65+ countries, with its technology supported by 700+ publications and 100+ partnerships. The company works with health systems, radiologists, pathologists, and biopharma companies to accelerate oncology innovation from drug discovery through companion diagnostics. Lunit's mission is to enable earlier cancer detection and more precise treatment, ultimately improving patient outcomes through intelligent, scalable AI solutions.

Mission & Story

Mission

Working toward a future where cancer is detected earlier and treated with greater precision, enabling better outcomes for patients

Clinical Focus

Medical conditions and clinical areas addressed by Lunit.

Breast cancerLung cancerChest abnormalitiesVarious oncology biomarkers (HER2, PD-L1)Tumor microenvironment analysis

Who It Serves

Health SystemsRadiology practicesHospitalsBiopharma companiesClinical trial organizationsPathology labs

Milestones & Awards

Recent Milestones

Surpassed 330+ sites and 1M annual screenings for breast imaging AI moving into clinical practice; presenting six AI studies at AACR 2026; highlighting IHC and tumor microenvironment research at ASCO 2026

Key Partnerships

100+ partnerships with imaging and diagnostics companiesBiopharma partners for clinical trials and companion diagnosticsGlobal radiology technology partners

Company Details

Headquarters
Seoul, Gangnam-gu, South Korea

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

FDA clearanceCE MarkISO 13485:2016ISO 27001:2022BS EN ISO 14971:2019Health Canada approvalTGA approvalMedsafe registration
Last updated Jun 30, 2026

Similar Companies in this Market

View all 189
A2z Radiology Ai

A2z Radiology Ai

AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.

Adas3D Medical S.L

Adas3D Medical S.L

11-50 employees

Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.

AEYE Health

AEYE Health

11-50 employees

AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.

Agfa HealthCare N.V.

Agfa HealthCare N.V.

AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.

AI4MedImaging Medical Solutions

AI4MedImaging Medical Solutions

AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.

Aidence

Aidence

Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.

Aidoc

Aidoc

growth · 350 employees

Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.

Aikenist Technologies Pvt Ltd

Aikenist Technologies Pvt Ltd

21-100 employees

Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.